Bone marrow-derived progenitor cells augment venous remodeling in a mouse dorsal skinfold chamber model

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Doyle, Megan E ^a   Perley, Jeffrey P ^a   Skalak, Thomas C ^a  

^a University of Virginia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CD45 ANTIGEN; CELL PROTEIN; CXCL2 CHEMOKINE; GAMMA INTERFERON; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN LIN; STEM CELL ANTIGEN 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PARAMETERS; BONE MARROW; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE COUNT; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SKINFOLD; STEM CELL TRANSPLANTATION; VENOUS REMODELING; VENULE; ANGIOGENESIS; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION PROFILING; METABOLISM; PHYSIOLOGY; STEM CELL; TISSUE ENGINEERING;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION PROFILING; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; TISSUE ENGINEERING; VENULES;

EID: 84857543151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032815     Document Type: Article

References (56)

1. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, et al. (2000) Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86: 1198-1202.
2. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, et al. (2004) Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94: 230-238.
3. Goodell MA, Jackson KA, Majka SM, Mi T, Wang H, et al. (2001) Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci 938: 208-218; discussion 218-220.
4. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, et al. (2003) Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89: 1235-1249.
5. Bobis S, Jarocha D, Majka M, (2006) Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol 44: 215-230.
6. Zhang HK, Zhang N, Wu LH, Jin W, Li M, et al. (2005) Therapeutic neovascularization with autologous bone marrow CD34+ cells transplantation in hindlimb ischemia. Zhonghua Wai Ke Za Zhi 43: 1275-1278.
7. Van Huyen JP, Smadja DM, Bruneval P, Gaussem P, Dal-Cortivo L, et al. (2008) Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia. Mod Pathol 21: 837-846.
8. Al-Khaldi A, Al-Sabti H, Galipeau J, Lachapelle K, (2003) Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 75: 204-209.
9. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, et al. (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107: 1395-1402.
10. Stepanovic V, Awad O, Jiao C, Dunnwald M, Schatteman GC, (2003) Leprdb diabetic mouse bone marrow cells inhibit skin wound vascularization but promote wound healing. Circ Res 92: 1247-1253.
11. Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J, Schatteman GC, (2003) CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res 40: 368-377.
12. Schatteman GC, Ma N, (2006) Old bone marrow cells inhibit skin wound vascularization. Stem Cells 24: 717-721.
13. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, et al. (2001) Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103: 897-903.
14. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA, (2000) Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106: 571-578.
15. Iwase T, Nagaya N, Fujii T, Itoh T, Murakami S, et al. (2005) Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 66: 543-551.
16. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, et al. (2001) Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37: 1726-1732.
17. Ichioka S, Kouraba S, Sekiya N, Ohura N, Nakatsuka T, (2005) Bone marrow-impregnated collagen matrix for wound healing: experimental evaluation in a microcirculatory model of angiogenesis, and clinical experience. Br J Plast Surg 58: 1124-1130.
18. Zhang G, Hu Q, Braunlin EA, Suggs LJ, Zhang J, (2008) Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. Tissue Eng Part A 14: 1025-1036.
19. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
20. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, et al. (2003) Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425: 968-973.
21. Tang YL, Zhao Q, Qin X, Shen L, Cheng L, et al. (2005) Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 80: 229-236; discussion 236-227.
22. Caplan AI, Dennis JE, (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98: 1076-1084.
23. Van Overstraeten-Schlogel N, Beguin Y, Gothot A, (2006) Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. Eur J Haematol 76: 488-493.
24. Wragg A, Mellad JA, Beltran LE, Konoplyannikov M, San H, et al. (2008) VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med 86: 1221-1232.
25. Sun J, Li SH, Liu SM, Wu J, Weisel RD, et al. (2009) Improvement in cardiac function after bone marrow cell therapy is associated with an increase in myocardial inflammation. Am J Physiol Heart Circ Physiol 296: H43-50.
26. Augst AD, Kong HJ, Mooney DJ, (2006) Alginate hydrogels as biomaterials. Macromol Biosci 6: 623-633.
27. Li Z, Gunn J, Chen MH, Cooper A, Zhang M, (2008) On-site alginate gelation for enhanced cell proliferation and uniform distribution in porous scaffolds. J Biomed Mater Res A 86: 552-559.
28. Morris CE, Skalak TC, (2007) Chronic static magnetic field exposure alters microvessel enlargement resulting from surgical intervention. J Appl Physiol 103: 629-636.
29. Carmeliet P, (2003) Angiogenesis in health and disease. Nat Med 9: 653-660.
30. Laham RJ, Li J, Tofukuji M, Post M, Simons M, et al. (2003) Spatial heterogeneity in VEGF-induced vasodilation: VEGF dilates microvessels but not epicardial and systemic arteries and veins. Ann Vasc Surg 17: 245-252.
31. Nickerson M, Burke C, Holliday C, Hull M, Song J, et al. Microvascular Diameter Responses to the Controlled Release of Platelet Derived Growth Factor-BB (PDGF-BB) and Transforming Growth Factor-ß1 (TGF-ß1). The FASEB Journal 2006: 20;A709; 2006.
32. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, et al. (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270: 12607-12613.
33. Lamb DJ, Modjtahedi H, Plant NJ, Ferns GA, (2004) EGF mediates monocyte chemotaxis and macrophage proliferation and EGF receptor is expressed in atherosclerotic plaques. Atherosclerosis 176: 21-26.
34. Schaper W, Scholz D, (2003) Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 23: 1143-1151.
35. Fiers W, (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 285: 199-212.
36. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, et al. (2000) CXC chemokines in angiogenesis. J Leukoc Biol 68: 1-8.
37. Baggiolini M, (1995) Activation and recruitment of neutrophil leukocytes. Clin Exp Immunol 101 (Suppl 1): 5-6.
38. Scapini P, Morini M, Tecchio C, Minghelli S, Di Carlo E, et al. (2004) CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J Immunol 172: 5034-5040.
39. Schreiber RD, Celada A, Buchmeier N, (1986) The role of interferon-gamma in the induction of activated macrophages. Ann Inst Pasteur Immunol 137C: 203-206.
40. Adair TH, Hang J, Wells ML, Magee FD, Montani JP, (1995) Long-term electrical stimulation of rabbit skeletal muscle increases growth of paired arteries and veins. Am J Physiol 269: H717-724.
41. Nugent HM, Sjin RT, White D, Milton LG, Manson RJ, et al. (2007) Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts. J Vasc Surg 46: 548-556.
42. Abeles D, Kwei S, Stavrakis G, Zhang Y, Wang ET, et al. (2006) Gene expression changes evoked in a venous segment exposed to arterial flow. J Vasc Surg 44: 863-870.
43. Komai Y, Nakano A, Seki J, Niimi H, (2005) Cell morphological changes in venous remodeling induced by arteriovenous grafting in rat limb. Clin Hemorheol Microcirc 32: 247-259.
44. Dorfmuller P, Humbert M, Perros F, Sanchez O, Simonneau G, et al. (2007) Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 38: 893-902.
45. Kwei S, Stavrakis G, Takahas M, Taylor G, Folkman MJ, et al. (2004) Early adaptive responses of the vascular wall during venous arterialization in mice. Am J Pathol 164: 81-89.
46. Heldin CH, Westermark B, (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316.
47. Aranguren XL, McCue JD, Hendrickx B, Zhu XH, Du F, et al. (2008) Multipotent adult progenitor cells sustain function of ischemic limbs in mice. J Clin Invest 118: 505-514.
48. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, et al. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.
49. Gnecchi M, He H, Liang OD, Melo LG, Morello F, et al. (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11: 367-368.
50. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201.
51. Wang Y, Bai Y, Qin L, Zhang P, Yi T, et al. (2007) Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation. Circ Res 101: 560-569.
52. Hood JD, Meininger CJ, Ziche M, Granger HJ, (1998) VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 274: H1054-1058.
53. Price RJ, Skalak TC, (1994) Circumferential wall stress as a mechanism for arteriolar rarefaction and proliferation in a network model. Microvasc Res 47: 188-202.
54. Price RJ, Skalak TC, (1996) Chronic alpha 1-adrenergic blockade stimulates terminal and arcade arteriolar development. Am J Physiol 271: H752-759.
55. Xiong M, Elson G, Legarda D, Leibovich SJ, (1998) Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 153: 587-598.
56. Nagaoka I, Honma S, Someya A, Iwabuchi K, Yamashita T, (1992) Differential expression of the platelet-derived growth factor-A and-B genes during maturation of monocytes to macrophages. Comp Biochem Physiol B 103: 349-356.